Nektar Therapeutics (NASDAQ:NKTR)

12.38
BATS BZX Real-Time Price
As of 11:24am ET
 -0.13 / -1.04%
Today’s Change
9.51
Today|||52-Week Range
17.53
-20.13%
Year-to-Date

Today’s Trading

Previous close12.51
Today’s open12.57
Day’s range12.23 - 12.64
Volume418,965
Average volume (3 months)1,974,740
Market cap$1.6B
Dividend yield--
Data as of 11:13am ET, 07/01/2015

Growth & Valuation

Earnings growth (last year)+70.00%
Earnings growth (this year)-26.19%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+34.77%
P/E ratio61.4
Price/Sales9.80
Price/Book45.18

Competitors

 Today’s
change
Today’s
% change
ARIAARIAD Pharmaceutical...-0.14-1.69%
FGENFibroGen Inc-0.25-1.06%
DBVTDBV Technologies SA+1.22+4.10%
PRAHPRA Health Sciences ...+0.01+0.01%
Data as of 11:27am ET, 07/01/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$200.7M
Annual profit (last year)-$53.9M
Net profit margin-26.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers